Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

SHE:000766 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,246	1,322	1,470	1,470	1,514	1,111
Other Revenue	0.5	0.5	3.57	0.58	1.32	0.72
Revenue	1,246	1,323	1,473	1,471	1,515	1,112
Revenue Growth (YoY)	-10.84%	-10.23%	0.18%	-2.95%	36.31%	-43.77%
Cost of Revenue	335.34	329.03	381.17	352.93	350.18	229.94
Gross Profit	910.88	993.53	1,092	1,118	1,165	881.86
Selling, General & Admin	694.76	789.26	905	923.47	986.24	1,042
Research & Development	49.84	50.34	45.82	64.91	63.52	50.33
Other Operating Expenses	13.52	9.88	10.62	11.57	5.4	3.96
Operating Expenses	758.65	853.14	970.43	996.86	1,052	1,228
Operating Income	152.23	140.39	121.75	120.96	113.33	-346.24
Interest Expense	-84.06	-84.98	-83.15	-88.79	-97.19	-125.27
Interest & Investment Income	2.07	5.28	4.02	11.5	26.36	23.31
Other Non Operating Income (Expenses)	-5.24	-2.66	1.23	-3.64	3.47	-0.37
EBT Excluding Unusual Items	65	58.03	43.85	40.02	45.98	-448.58
Gain (Loss) on Sale of Investments	-0	0.03	-2.61	-0.05	-0.01	-
Gain (Loss) on Sale of Assets	-0.03	-0.17	-0.21	-0.02	0.83	57.58
Asset Writedown	2.15	-0.12	0.22	-0.11	-1.49	-0.43
Other Unusual Items	8.76	9.32	13.61	10.33	14.32	35.6
Pretax Income	75.88	67.09	54.86	50.17	59.62	-355.83
Income Tax Expense	18.77	11.11	11.63	20.99	25.64	4.83
Earnings From Continuing Operations	57.11	55.98	43.23	29.19	33.99	-360.66
Minority Interest in Earnings	0.37	0.46	0.71	0.96	1.29	1.16
Net Income	57.48	56.44	43.93	30.15	35.27	-359.5
Net Income to Common	57.48	56.44	43.93	30.15	35.27	-359.5
Net Income Growth	9.88%	28.46%	45.71%	-14.52%	-	-
Shares Outstanding (Basic)	943	941	879	1,005	882	972
Shares Outstanding (Diluted)	943	941	879	1,005	882	972
Shares Change (YoY)	7.41%	7.05%	-12.57%	13.97%	-9.24%	0.40%
EPS (Basic)	0.06	0.06	0.05	0.03	0.04	-0.37
EPS (Diluted)	0.06	0.06	0.05	0.03	0.04	-0.37
EPS Growth	2.30%	20.00%	66.67%	-25.00%	-	-
Free Cash Flow	66.56	113.58	86.11	174.42	112.85	61.55
Free Cash Flow Per Share	0.07	0.12	0.10	0.17	0.13	0.06
Gross Margin	73.09%	75.12%	74.13%	76.00%	76.89%	79.32%
Operating Margin	12.21%	10.62%	8.26%	8.22%	7.48%	-31.14%
Profit Margin	4.61%	4.27%	2.98%	2.05%	2.33%	-32.34%
Free Cash Flow Margin	5.34%	8.59%	5.85%	11.86%	7.45%	5.54%
EBITDA	208.92	204.82	196.49	192.58	182.72	-278.53
EBITDA Margin	16.76%	15.49%	13.34%	13.09%	12.06%	-25.05%
D&A For EBITDA	56.69	64.42	74.74	71.62	69.39	67.71
EBIT	152.23	140.39	121.75	120.96	113.33	-346.24
EBIT Margin	12.21%	10.62%	8.26%	8.22%	7.48%	-31.14%
Effective Tax Rate	24.74%	16.56%	21.20%	41.83%	42.99%	-
Revenue as Reported	1,246	1,323	1,473	1,471	1,515	1,112
Advertising Expenses	-	249.73	352.83	298.68	375.06	299.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.